For many stroke survivors, recovery is derailed by painful muscle stiffness and involuntary spasms that limit movement, ...
The two mainstays of nonpharmacological spasticity management are the removal of noxious stimuli that can drive hypertonicity and the application of physical modalities. Comorbidities of neurological ...
Three medications have spasticity reduction as their primary indication: baclofen (Lioresal ®), dantrolene (Dantrium ®), and tizanidine (Zanaflex ®). These drugs represent the mainstays of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results